Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2013 Mar:32 Suppl 1:S97-101.
doi: 10.1007/s10067-010-1561-9. Epub 2010 Sep 23.

Successful remission induction with a combination therapy of rituximab, cyclophosphamide, and steroids in a patient with refractory optic neuritis in Wegener's granulomatosis

Affiliations
Case Reports

Successful remission induction with a combination therapy of rituximab, cyclophosphamide, and steroids in a patient with refractory optic neuritis in Wegener's granulomatosis

Cord Huchzermeyer et al. Clin Rheumatol. 2013 Mar.

Abstract

A 56-year old patient with a history of limited Wegener's granulomatosis presented with signs and symptoms of optic neuritis. Radiologic signs of orbital inflammation were absent. Testing of visual acuity and visual field allowed close monitoring of disease activity. Thus, rapid improvement of visual function was achieved with high-dose steroids. Despite maintenance therapy with cyclophosphamide recurrence occurred repeatedly as soon as tapering of steroids was begun. After remission induction with rituximab, the patient retained good visual function under maintenance therapy with azathioprine and low-dose corticosteroids. Optic neuritis in Wegener's granulomatosis without signs of orbital involvement is rare and most likely caused by occlusive vasculitis of the vasa nervorum. In this patient with optic neuritis refractory to conventional therapy, rituximab in combination with cyclophosphamide and corticosteroids was well tolerated and successfully used for remission induction, followed by maintenance therapy with azathioprine and low dose corticosteroids.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Q J Med. 1993 Nov;86(11):719-25 - PubMed
    1. Mayo Clin Proc. 1997 May;72(5):440-4 - PubMed
    1. Klin Monbl Augenheilkd. 1982 Sep;181(3):184-7 - PubMed
    1. Kidney Int. 2007 Sep;72(6):676-82 - PubMed
    1. J Neurol Neurosurg Psychiatry. 1989 Jul;52(7):918 - PubMed

Publication types

MeSH terms

LinkOut - more resources